Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Key Humira patent goes down via IPR—but biosims makers shouldn't celebrate yet, analysts warn
Key Humira patent goes down via IPR—but biosims makers shouldn't celebrate yet, analysts warn
Key Humira patent goes down via IPR—but biosims makers shouldn't celebrate yet, analysts warn
Submitted by
admin
on May 18, 2017 - 12:09am
Source:
Fierce Pharma
News Tags:
Humira
patents
AbbVie
biosimilars
Headline:
Key Humira patent goes down via IPR—but biosims makers shouldn't celebrate yet, analysts warn
Do Not Allow Advertisers to Use My Personal information
